Impact of MLH1 expression on tumor evolution after curative surgical tumor resection in a murine orthotopic xenograft model for human MSI colon cancer

Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients

(2016) Amos Kirilovsky et al.   INTERNATIONAL IMMUNOLOGY

Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy

(2016) P. D. Dunne et al.   Cancer Immunology Research

Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data

(2015) M. Nunes et al.   CANCER RESEARCH

A molecular signature for the prediction of recurrence in colorectal cancer

(2015) Lisha Wang et al.   Molecular Cancer

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

(2015) Dung T. Le et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic Classifier ColoPrint Predicts Recurrence in Stage II Colorectal Cancer Patients More Accurately Than Clinical Factors

(2015) S. Kopetz et al.   ONCOLOGIST

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer

(2013) Matthias Maak et al.   ANNALS OF SURGERY

Identification of Candidate Oncogenes in Human Colorectal Cancers With Microsatellite Instability

(2013) Alexandra E. Gylfe et al.   GASTROENTEROLOGY

Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer

(2012) S. Julien et al.   CLINICAL CANCER RESEARCH

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis

(2012) Trude H Ågesen et al.   GUT

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

(2012) A. D. Roth et al.   JNCI-Journal of the National Cancer Institute

Patient-derived tumour xenografts as models for oncology drug development

(2012) John J. Tentler et al.   Nature Reviews Clinical Oncology

Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review

(2012) Rebeca Sanz-Pamplona et al.   PLoS One

Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy

(2011) A. Zaanan et al.   CLINICAL CANCER RESEARCH

Restoration of Transforming Growth Factor-β Receptor II Expression in Colon Cancer Cells with Microsatellite Instability Increases Metastatic Potentialin Vivo

(2011) Xiao-Qiong Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

TGFBR2 and BAX Mononucleotide Tract Mutations, Microsatellite Instability, and Prognosis in 1072 Colorectal Cancers

(2011) Kaori Shima et al.   PLoS One

A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

(2011) A. Bertotti et al.   Cancer Discovery

Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications

(2011) Aziz Zaanan et al.   CELLULAR ONCOLOGY

Specific genomic aberrations in primary colorectal cancer are associated with liver metastases

(2010) Sjoerd C Bruin et al.   BMC CANCER

Defective Mismatch Repair, Microsatellite Mutation Bias, and Variability in Clinical Cancer Phenotypes

(2010) S. N. Shah et al.   CANCER RESEARCH

Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes

(2010) Toshiaki Watanabe et al.   EUROPEAN JOURNAL OF CANCER

The Chromosomal Instability Pathway in Colon Cancer

(2010) Maria S. Pino et al.   GASTROENTEROLOGY

Microsatellite Instability in Colorectal Cancer

(2010) C. Richard Boland et al.   GASTROENTEROLOGY

Colorectal cancer molecular biology moves into clinical practice

(2010) C. C. Pritchard et al.   GUT

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

(2010) Ramon Salazar et al.   JOURNAL OF CLINICAL ONCOLOGY

Mismatch repair deficient colorectal cancer in the era of personalized treatment

(2010) Madeleine Hewish et al.   Nature Reviews Clinical Oncology

Microsatellite instability in colorectal cancer—the stable evidence

(2010) Eduardo Vilar et al.   Nature Reviews Clinical Oncology

Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin

(2009) A. Zaanan et al.   ANNALS OF ONCOLOGY

Clinical implications of microsatellite instability in sporadic colon cancers

(2009) Frank A Sinicrope et al.   CURRENT OPINION IN ONCOLOGY

SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology

(2009) Stefan M. Woerner et al.   NUCLEIC ACIDS RESEARCH

Hypermutability of Genes in Homo sapiens Due to the Hosting of Long Mono-SSR

(2008) E. Loire et al.   MOLECULAR BIOLOGY AND EVOLUTION

Comparative lesion sequencing provides insights into tumor evolution

(2008) S. Jones et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA